Vanguard Personalized Indexing Management
AZN icon

Vanguard Personalized Indexing Management’s AstraZeneca AZN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
72,561
+2,864
+4% +$539K 0.11% 135
2026
Q1 		$13.7M Sell
69,697
-1,531
-2% -$295K 0.13% 124
2025
Q4 		$13.1M Buy
71,228
+4,074
+6% +$715K 0.13% 117
2025
Q3 		$10.3M Buy
67,154
+5,389
+9% +$816K 0.11% 156
2025
Q2 		$8.64M Buy
61,765
+4,096
+7% +$574K 0.1% 180
2025
Q1 		$8.48M Buy
57,669
+9,070
+19% +$1.31M 0.13% 145
2024
Q4 		$6.37M Buy
48,599
+288
+0.6% +$40.3K 0.1% 173
2024
Q3 		$7.53M Buy
48,311
+1,577
+3% +$255K 0.12% 138
2024
Q2 		$6.59M Buy
46,734
+15,947
+52% +$2.4M 0.13% 135
2024
Q1 		$4.17M Buy
30,787
+4,109
+15% +$544K 0.09% 204
2023
Q4 		$3.59M Sell
26,678
-3,931
-13% -$511K 0.09% 200
2023
Q3 		$4.15M Buy
30,609
+1,505
+5% +$206K 0.12% 142
2023
Q2 		$4.17M Buy
29,104
+3,803
+15% +$560K 0.13% 138
2023
Q1 		$3.51M Sell
25,301
-146
-0.6% -$19.6K 0.12% 152
2022
Q4 		$3.45M Buy
25,447
+870
+4% +$109K 0.14% 137
2022
Q3 		$2.7M Sell
24,577
-915
-4% -$116K 0.12% 161
2022
Q2 		$3.37M Buy
25,492
+6,206
+32% +$814K 0.16% 117
2022
Q1 		$2.56M Buy
19,286
+8,343
+76% +$1M 0.12% 148
2021
Q4 		$1.27M Buy
10,943
+1,304
+14% +$153K 0.08% 287
2021
Q3 		$1.16M Buy
9,639
+3,256
+51% +$379K 0.1% 195
2021
Q2 		$765K Sell
6,383
-705
-10% -$77.3K 0.08% 306
2021
Q1 		$705K Sell
7,088
-564
-7% -$56.7K 0.11% 222
2020
Q4 		$765K Sell
7,652
-564
-7% -$59.7K 0.17% 135
2020
Q3 		$900K Buy
8,216
+2,304
+39% +$256K 0.25% 87
2020
Q2 		$625K Buy
5,912
+3,180
+116% +$328K 0.28% 85
2020
Q1 		$244K Buy
+2,732
New +$257K 0.14% 187

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Personalized Indexing Management's AZN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its AstraZeneca (AZN) stake by 4.1% in Q2 2026, buying an estimated $539K and bringing the position to 72,561 shares worth $13.8M. The position accounts for 0.11% of the portfolio, ranked #135.

Vanguard Personalized Indexing Management first reported a position in AZN in Q1 2020 and has held it in 26 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 72,561 shares of AstraZeneca worth $13.8M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 2,864 AstraZeneca shares in Q2 2026, an estimated $539K.
  • AstraZeneca made up 0.11% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #135 holding.
  • Vanguard Personalized Indexing Management first reported a position in AstraZeneca in Q1 2020 and has held it in 26 quarters since.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.